Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

J&J Submits NDA For Novel Antibiotic Doripenem

15 Dec 2006

• By Daniel Fowler

Drug could reach market by October 2007.

Related Content

J&amp;J Acquires Phase III Antibiotic Via Peninsula Purchase

19 Apr 2005

Wyeth Antibiotic Tygacil Approved For Broad-Spectrum, Early Use

16 Jun 2005

Forest Acquisition Of Cerexa Could Set The Stage For Ceftaroline Launch In 2010

14 Dec 2006

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2024 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.